Navigation Links
Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
Date:2/26/2009

RALEIGH, N.C., Feb. 26 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched XYLAREX - a first-in-class nonantibiotic for the dietary management of recurrent acute otitis media (middle ear infections). XYLAREX is a novel oral solution intended to be administered daily to reduce the number of ear infections children experience. The primary ingredient in XYLAREX has also been shown to reduce the amount of antibiotics prescribed to children affected by middle ear infections. XYLAREX can be administered to children as young as six months of age.

Acute Otitis Media (AOM) is the most common bacterial illness of childhood and the primary reason antibiotics are prescribed for children in the U.S. Recurrent AOM affects millions of U.S. children each year, and children suffering from repeated, painful ear infections are frequently exposed to numerous courses of antibiotics at a young age. With repeated antibiotic exposure there is an increased risk of developing bacterial resistance, which the Centers for Disease Control and Prevention (CDC) call one of the world's most pressing health concerns.

"Until now there have been limited options for managing children with recurrent acute otitis media. Pediatricians and otolaryngologists alike see many children with recurrent ear infections who have been subjected to countless antibiotic courses and - in severe cases - may require ear tube placement to alleviate symptoms. Parents and clinicians are looking for new options for these children. A novel, non-drug product like XYLAREX is an important new option for managing children with recurrent AOM in order to reduce their infections and decrease their need for antibiotics," says Mark Mehle, M.D., a practicing ear, nose, and throat physician in Cleveland, Ohio.

According to Jarrett Disbrow, Presiden
'/>"/>

SOURCE Arbor Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
2. Cold Spring Harbor scientists devise novel, low-cost method of sifting genomes high-value regions
3. Cold Spring Harbor Protocols features innovative methods for embryology research
4. Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils
5. Cold Spring Harbor Protocols features high-throughput methods for analyzing gene activity
6. Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation
7. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
8. Does 1q31.1-32.1 harbor a tumor suppressor gene related to Chinese SCC patients?
9. Cold Spring Harbor scientists reveal a proteins role in enabling AIDS virus to reproduce
10. Cold Spring Harbor science teams identify 13 new tumor-suppressor genes in liver cancer
11. Announcing a Monumental Sharing of Laser Innovation: The American Society for Laser Medicine and Surgery (ASLMS) Holds 29th Annual Conference in National Harbor, Md., April 1 - 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The American Brain Tumor Association ... 2014-2016 Basic Research Fellowships and 2014-2015 Discovery Grant Awards. ... is seeding the field with talented, bright young investigators ... the causes, effects, diagnosis and treatment of brain tumors. ... based on the potential to advance the understanding and ...
(Date:8/27/2014)... the onset of a cancer defense mechanism known ... Cancer Center are leveraging it in a new ... cell death rather than survival. The novel treatment ... referred to as the "Trash Man" due to ... autophagy. Results from preclinical experiments suggest this experimental ...
(Date:8/27/2014)... Cash House 's contributions to Horizons ... upkeep of the shelter including new initiatives and a wide ... the lives of each youth who walk through their door. ... for youth ages 16-25. Not only does Horizons operate as ... for the youth who come through their doors. Horizons has ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 IQ ... supplements, today announced its continued support of the Cystic ... Formulations participated in a fundraising campaign led by TigerFitness.com ... of IQ Formulations’ sales were donated to the respected ... to a TigerFitness.com fundraiser to support Isla, a young ...
(Date:8/27/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... AND REGENERATIVE PRODUCTS , the global market for advanced ... by 2014-end to $42.2 billion by 2019, with a ... to 2019. New technologies and an increasingly older population ... market. , While there are many conventional and generally ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... study report based on detainee interrogations finds that ... not involve physical pain—such as psychological// manipulation, deprivation, ... much mental distress and traumatic stress as physical ... torture encompass both physical and mental pain and ...
... that nearly four out of five hospitalized children receive ... adults//. The authors fear that treating children with off-label ... the magnitude of off-label use of drugs in children," ... specializing in infectious diseases at The Children’s Hospital of ...
... been a success, but continued commitment from the government is ... officials. ,The Immunization Plus Days (IPDs) initiative was ... (NPI) ¯ a government initiative with support from UNICEF and ... 18 northern regions still affected by the virus. ...
... Scientists have developed a test for the early diagnosis of lung ... and off in cells// lining the airways leading to the lungs ... effective. ,Lung cancer is the most deadly form of ... men and the third most common in women. In 2002 about ...
... University researchers have released results of a study showing ... intake//, higher body weight, a decrease in calcium and ... ,The report also noted that studies funded ... show detrimental effects from soft drinks than studies that ...
... the accurate amount of fat in a human body, according// to ... for measuring the amount of fat in a person's body. It ... of their height. ,Generally, a BMI of 25 or ... A person with a higher BMI is thought to be at ...
Cached Medicine News:Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 2Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 3Health News:Prescribing Off Label Drugs for Children may Be Hazardous 2Health News:Prescribing Off Label Drugs for Children may Be Hazardous 3Health News:Nigerian Programme Increases Polio Immunisation 2Health News:Gene Cell Test may Aid Early Lung Cancer Diagnosis 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... -- After the February 2014 launch of their new ... medical practices and management companies, Prime Clinical is reporting ... "The feedback has been great," says Director of ... of demos and new sign-ups is a reflection of ... of software features." Prime Clinical developed ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: